REFERENCES 1. Monneaux F, Lozano JM, Patarroyo ME, et al. T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice. Eur J Immunol 2003;33:287–96. 2. Muller S, Monneaux F, Schall N, et al. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Arthritis Rheum 2008;58:3873–83. 3. Dieker J, Cisterna B, Monneaux F, et al. Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K. Cell Death Differ 2008;15:793–804. 4. Monneaux F, Hoebeke J, Sordet C, et al. Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analog. J Immunol 2005;175:5839–47. 5. Page N, Schall N, Strub JM, et al. The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism medi- ated by gammadelta T cells. PLoS ONE 2009;4:e5273. 6. Monneaux F, Parietti V, Briand JP, et al. Importance of spliceosomal RNP1 motif for intermolecular T-B cell spreading and tolerance restoration in lupus. Arthritis Res Ther 2007;9:R111. 7. Freeman BC, Myers MP, Schumacher R, et al. Identiﬁcation of a regulatory motif in Hsp70 that affects ATPase activity, substrate binding and interaction with HDJ-1. EMBO J 1995;14:2281–92. 8. Terada K, Kanazawa M, Bukau B, et al. The human DnaJ homologue dj2 facilitates mitochondrial protein import and luciferase refolding. J Cell Biol 1997;139:1089–95. 9. Mae T, Nemoto K, Sugawara Y, et al. Therapeutic studies of the combination of deoxyspergualin and prednisolone in MRL/lpr mice with advanced lupus-like disease. J Antibiot 1994;47:90–4. 10. Auger I, Escola JM, Gorvel JP, et al. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med 1996;2:306–10. 11. Panjwani N, Akbari O, Garcia S, et al. The HSC73 molecular chaperone: involvement in MHC class II antigen presentation. J Immunol 1999;163:1936–42. 12. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002;2:185–94. 13. Houlihan JL, Metzler JJ, Blum JS. HSP90alpha and HSP90beta isoforms selectively modulate MHC class II antigen presentation in B cells. J Immunol 2009;182:7451–8. 14. Zhou D, Li P, Lin Y, et al. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005;22:571–81. 15. Buschow SI, van Balkom BW, Aalberts M, et al. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 2010;88:1–6. Extended report 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. Kon M, Cuervo AM. Chaperone-mediated autophagy in health and disease. FEBS Lett 2010;584:1399–404. Crotzer VL, Blum JS. Autophagy and its role in MHC-mediated antigen presentation. J Immunol 2009;182:3335–41. Münz C. Enhancing immunity through autophagy. Annu Rev Immunol 2009;27:423–49. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010;140:313–26. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science 2004;306:990–5. Hartleben B, Gödel M, Meyer-Schwesinger C, et al. Autophagy inﬂuences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010;120:1084–96. Bjørkøy G, Lamark T, Brech A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005;171:603–14. Komatsu M, Waguri S, Koike M, et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deﬁcient mice. Cell 2007;131:1149–63. Beckmann RP, Mizzen LE, Welch WJ. Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly. Science 1990;248:850–4. Mayer MP, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell Mol Life Sci 2005;62:670–84. Nedjic J, Aichinger M, Mizushima N, et al. Macroautophagy, endogenous MHC II loading and T cell selection: the beneﬁts of breaking the rules. Curr Opin Immunol 2009;21:92–7. Arndt V, Dick N, Tawo R, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010;20:143–8. Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009;137:1001–4. Yu HB, Kielczewska A, Rozek A, et al. Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide. J Biol Chem 2009;284:36007–11. Komatsu M, Ichimura Y. Physiological signiﬁcance of selective degradation of p62 by autophagy. FEBS Lett 2010;584:1374–8. Nakamura K, Kimple AJ, Siderovski DP, et al. PB1 domain interaction of p62/ sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem 2010;285:2077–89. Monneaux F, Parietti V, Briand JP, et al. Intramolecular T cell spreading in unprimed MRL/lpr mice: importance of the U1-70k protein sequence 131-151. Arthritis Rheum 2004;50:3232–8. Ann Rheum Dis 2011;70:837–843. doi:10.1136/ard.2010.139832 843